ATE286596T1 - Chemische modifikation von antikörpern und antigenen - Google Patents

Chemische modifikation von antikörpern und antigenen

Info

Publication number: ATE286596T1
Authority: AT; Austria
Prior art keywords: antigens; antibodies; chemical modification; chemically modified; modified antibodies
Prior art date: 1994-02-19

Application number

AT95301020T

Other languages

English (en)

Inventor

Adrian Charles Dawkes

John Arthur Diment

Graham Delisle Yearwood

Original Assignee

Ortho Clinical Diagnostics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-19

Filing date

1995-02-17

Publication date

2005-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10750624&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE286596(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-02-17 Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE286596T1 publication Critical patent/ATE286596T1/de

Links

239000000427 antigen Substances 0.000 title abstract 5
102000036639 antigens Human genes 0.000 title abstract 5
108091007433 antigens Proteins 0.000 title abstract 5
238000007385 chemical modification Methods 0.000 title abstract 2
238000003018 immunoassay Methods 0.000 abstract 3
238000000034 method Methods 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT95301020T 1994-02-19 1995-02-17 Chemische modifikation von antikörpern und antigenen ATE286596T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9403215A GB9403215D0 (en)	1994-02-19	1994-02-19	Chemical modification of antibodies and antigens

Publications (1)

Publication Number	Publication Date
ATE286596T1 true ATE286596T1 (de)	2005-01-15

Family

ID=10750624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95301020T ATE286596T1 (de)	1994-02-19	1995-02-17	Chemische modifikation von antikörpern und antigenen

Country Status (6)

Country	Link
US (1)	US6197533B1 (de)
EP (1)	EP0674175B1 (de)
JP (1)	JPH0850132A (de)
AT (1)	ATE286596T1 (de)
DE (1)	DE69533904T2 (de)
GB (1)	GB9403215D0 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9487823B2 (en) *	2002-12-20	2016-11-08	Qiagen Gmbh	Nucleic acid amplification
US8043834B2 (en) *	2003-03-31	2011-10-25	Qiagen Gmbh	Universal reagents for rolling circle amplification and methods of use
US8309303B2 (en) *	2005-04-01	2012-11-13	Qiagen Gmbh	Reverse transcription and amplification of RNA with simultaneous degradation of DNA
EP1762627A1 (de)	2005-09-09	2007-03-14	Qiagen GmbH	Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
DE102006020885A1 (de) *	2006-05-05	2007-11-08	Qiagen Gmbh	Einführung von Sequenzelementen in Nukleinsäuren
CN115141266A (zh) *	2022-08-02	2022-10-04	英科新创(厦门)科技股份有限公司	一种tp17蛋白的化学修饰方法及其产物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4914040A (en) *	1988-03-03	1990-04-03	Boehringer Mannheim Gmbh	Reagent and method for determination of a polyvalent substance using an immunoaggregate
US5484706A (en)	1993-05-19	1996-01-16	Pasteur Sanofi Diagnostics	Immunoassay for analytes in samples using alkylating agents

1994
- 1994-02-19 GB GB9403215A patent/GB9403215D0/en active Pending
1995
- 1995-02-10 US US08/386,390 patent/US6197533B1/en not_active Expired - Lifetime
- 1995-02-17 DE DE69533904T patent/DE69533904T2/de not_active Revoked
- 1995-02-17 AT AT95301020T patent/ATE286596T1/de not_active IP Right Cessation
- 1995-02-17 EP EP95301020A patent/EP0674175B1/de not_active Revoked
- 1995-02-17 JP JP7052022A patent/JPH0850132A/ja active Pending

Also Published As

Publication number	Publication date
DE69533904T2 (de)	2005-12-01
DE69533904D1 (de)	2005-02-10
EP0674175B1 (de)	2005-01-05
GB9403215D0 (en)	1994-04-13
EP0674175A3 (de)	1997-06-04
EP0674175A2 (de)	1995-09-27
US6197533B1 (en)	2001-03-06
JPH0850132A (ja)	1996-02-20

Similar Documents

Publication	Publication Date	Title
ATE278192T1 (de)	2004-10-15	Einfaches immunochemisches semiquantitatives bestimmungsverfahren und gerät
DE58902586D1 (de)	1992-12-10	Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
ATE315228T1 (de)	2006-02-15	Immunoassay zum bestimmen von bnp
ES2151528T3 (es)	2001-01-01	Composicion de calibrador o control para un ensayo de serologia igm.
ATE118275T1 (de)	1995-02-15	Immunoassayverfahren zum nachweis von antigenen.
ATE115729T1 (de)	1994-12-15	Testverfahren und reagenziensatz dafür.
ATE202116T1 (de)	2001-06-15	Antikörperklassenspezifisches entstörungsreagenz
ATE79678T1 (de)	1992-09-15	Bestimmung von monokinen.
ATE254286T1 (de)	2003-11-15	Zwei-inkubations mit markiertem antigen verwendenes immunoassay
DE3850249D1 (de)	1994-07-21	Nachweis von analyt in partikel enthaltenden proben.
ATE80466T1 (de)	1992-09-15	Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion.
DE69533904D1 (de)	2005-02-10	Chemische Modifikation von Antikörpern und Antigenen
DE3686717D1 (de)	1992-10-15	Immuntestverfahren.
KR950703061A (ko)	1995-08-23	Fk506-결합 단백질을 인식하는 모노클로날 항체, fk506-결합 단백질의 농도를 분석하는 방법 및 이를 위한 키트(monoclonal antibody recognizing fk506-binding protein, method for assaying fk506-binding protein level, and kit therefor)
ATE208040T1 (de)	2001-11-15	Immunoassay-reagenzien, testsätze und verfahren
CA2123069A1 (en)	1994-11-20	Immunoassay for analytes in samples using alkylating agents
DE69526056D1 (de)	2002-05-02	Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
ATE285075T1 (de)	2005-01-15	Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
ITMI930477A1 (it)	1994-09-12	Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
DE68919521D1 (de)	1995-01-12	Immuntest zum Nachweis von alpha-Haloacetamiden.
DE3863270D1 (de)	1991-07-18	Immuntest.

Legal Events

Date	Code	Title	Description
2005-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties